Skip to content

Oncotelic Therapeutics, Inc.: filings

Every Oncotelic Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 63 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-13fiscal Q2 202632930001493152-26-037857
10-Q2026-05-14fiscal Q1 202629590001493152-26-023181
10-K2026-04-15fiscal FY 202531600001493152-26-016838
10-Q2025-11-17fiscal Q3 202524740001493152-25-023834
10-Q2025-08-13fiscal Q2 202526810001641172-25-023568
10-Q2025-05-15fiscal Q1 202526550001641172-25-010984
10-K2025-04-15fiscal FY 202424490001641172-25-004846
10-Q2024-11-19fiscal Q3 202427870001493152-24-046867
10-Q2024-08-14fiscal Q2 202424720001493152-24-031995
10-Q2024-05-15fiscal Q1 202427570001493152-24-019332
10-K2024-04-12fiscal FY 202332610001493152-24-014475
10-Q2023-11-14fiscal Q3 202329910001493152-23-040804
10-Q2023-08-18fiscal Q2 202326760001493152-23-029461
10-Q2023-05-22fiscal Q1 202327540001493152-23-018430
10-K/A2023-04-20fiscal FY 202233660001493152-23-012978
10-K2023-04-14fiscal FY 202233660001493152-23-012352
10-Q2022-11-18fiscal Q3 2022331000001493152-22-032950
10-Q2022-08-22fiscal Q2 202233940001493152-22-023658
10-Q2022-05-23fiscal Q1 202231610001493152-22-014681
10-K2022-04-15fiscal FY 202134660001493152-22-010094
10-Q2021-11-22fiscal Q3 202133930001493152-21-029599
10-Q2021-08-20fiscal Q2 202134970001493152-21-020818
10-Q2021-05-24fiscal Q1 202130590001493152-21-012700
10-K2021-04-15fiscal FY 202033620001493152-21-008920
10-Q2020-11-16fiscal Q3 202032860001493152-20-021414
10-Q2020-08-14fiscal Q2 202036980001493152-20-015593
10-Q2020-06-29fiscal Q1 202031580001493152-20-011997
10-K2020-05-14fiscal FY 201930510001493152-20-008845
10-Q2019-11-19fiscal Q3 201925670001493152-19-018042
10-Q2019-08-19fiscal Q2 201924610001493152-19-012894
10-Q2019-05-15fiscal Q1 201919400001193125-19-147291
10-K2019-04-10fiscal FY 201825480001193125-19-102832
10-Q2018-11-14fiscal Q3 201823550001193125-18-326323
10-Q2018-08-14fiscal Q2 201821530001193125-18-248505
10-Q2018-05-14fiscal Q1 201819380001193125-18-161661
10-K2018-04-17fiscal FY 201722460001193125-18-119206
10-Q2017-11-14fiscal Q3 201719510001193125-17-341829
10-Q2017-08-02fiscal Q2 201719500001193125-17-245861
10-Q2017-05-08fiscal Q1 201719400001193125-17-162614
10-K2017-03-30fiscal FY 201624480001193125-17-103621
10-Q2016-11-14fiscal Q3 201621520001193125-16-766839
10-Q2016-08-02fiscal Q2 201621530001193125-16-668383
10-Q2016-05-06fiscal Q1 201620410001193125-16-582065
10-K2016-03-25fiscal FY 201523470001193125-16-518083
10-Q2015-11-12fiscal Q3 201520510001193125-15-375238
10-Q2015-08-06fiscal Q2 201520520001193125-15-280950
10-Q2015-05-07fiscal Q1 201519380001193125-15-176991
10-K2015-03-30fiscal FY 201425590001193125-15-111261
10-Q2014-11-13fiscal Q3 201421530001193125-14-410532
10-Q2014-08-08fiscal Q2 201423570001193125-14-302383
10-Q2014-05-08fiscal Q1 201421410001193125-14-189844
10-K2014-03-20fiscal FY 201326640001193125-14-108092
10-Q2013-11-13fiscal Q3 201324620001193125-13-438876
10-Q/A2013-10-18fiscal Q2 201325660001193125-13-404110
10-Q2013-08-12fiscal Q2 201324620001193125-13-331171
10-Q2013-05-09fiscal Q1 201324490001193125-13-210982
10-K2013-03-15fiscal FY 201227680001193125-13-110175
10-Q2012-11-09fiscal Q3 201225650001193125-12-463729
10-Q2012-08-13fiscal Q2 201225650001193125-12-351750
10-Q2012-05-11fiscal Q1 201226530001193125-12-227653
10-K2012-03-28fiscal FY 201130750001193125-12-137327
10-Q2011-11-10fiscal Q3 201126670000950123-11-097496
10-Q2011-08-12fiscal Q2 201126650000950123-11-076704

Inspect the source

Entity
Oncotelic Therapeutics, Inc. / CIK 0000908259
Captured
2026-09-20T05:05:47.535Z
SEC response SHA-256
6c0026f9e455c874f284117994b59a028bad3a82bccf268424724837d8c3b9db

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000908259.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))